Overview/General Research
- Characteristics of Integrase Inhibitor, Fusion Inhibitor and CCR5 Antagonist (PDF) (January 10, 2011)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Future of AIDS Gels May Lie in Drugs, Experts Say (March 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Vicriviroc Does Not Outdo Placebo Regimen in Phase 3 Trials (February 18, 2010)
From National AIDS Treatment Advocacy Project
- Genotypic Test Matches Tropism Test in Predicting Who Benefits From CCR5 Inhibitors (July 28, 2009)
A genotypic test is just as accurate as a more expensive tropism test in determining which treatment-experienced patients are suitable for treatment with the CCR5 inhibitor maraviroc, researchers from the University of British Columbia reported.
From aidsmap.com
- New Anti-HIV Therapies: Entry Inhibitors (January 2003)
From Project Inform
- Entry Inhibitors: The Bouncers at the Door (Winter 2002/2003)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
- New Targets Bring New Challenges (March 2002)
[Archived Article]
A closer look at integrase and entry inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis